Poly Medicure Share Price Today (POLYMED)
Today’s Poly Stock Read
Poly Medicure is trading down 0.04% at ₹1,650.2. With a market cap of ₹16,724.32 Cr, it trades at a P/E of 51.92. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
Poly Medicure is trading down 0.04% at ₹1,650.2. With a market cap of ₹16,724.32 Cr, it trades at a P/E of 51.92. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
Poly Medicure Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Poly Medicure Limited, framed against the sector median so the premium or discount is obvious at a glance.
Poly Medicure Limited trades at a P/E of 51.92× and P/B of 5.38×, against the Healthcare sector median P/E of 43.28×.
Valuation
Profitability
Growth
Financial Health
Poly Medicure Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Poly Medicure Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Poly Medicure Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Poly Medicure Limited, switchable between annual and quarterly views, consolidated or standalone.
Poly Medicure Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹16,724.32 Cr and reported EPS of ₹31.68.
| Period | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 611 | 687 | 786 | 923 | 1,115 | 1,376 | 1,670 | 1,875 |
| Other Income | 18 | 18 | 18 | 38 | 36 | 59 | 89 | 120 |
| Total Income | 629 | 706 | 805 | 961 | 1,151 | 1,435 | 1,759 | 1,995 |
| Cost of Goods Sold (COGS) | 209 | 217 | 262 | 348 | 406 | 483 | 555 | 597 |
| Gross Profit | 402 | 470 | 525 | 575 | 709 | 893 | 1,115 | 1,278 |
| +Operating Expenses | 273 | 306 | 310 | 362 | 444 | 535 | 662 | 836 |
| EBITDA | 129 | 164 | 214 | 213 | 265 | 358 | 453 | 442 |
| +Non-Operating Expenses | 50 | 59 | 56 | 58 | 66 | 75 | 95 | 127 |
| Profit Before Tax (PBT) | 100 | 124 | 177 | 193 | 236 | 342 | 447 | 422 |
| +Tax Expense | 35 | 30 | 44 | 49 | 58 | 86 | 114 | 107 |
| Total Profit for Period | 65 | 96 | 136 | 147 | 179 | 258 | 339 | 321 |
| Less: Non-controlling Interests | — | — | — | — | — | — | — | -1 |
| Net Profit (Owner's PAT) | 65 | 96 | 136 | 147 | 179 | 258 | 339 | 322 |
| Earnings Per Share (EPS) | 7.41 | 10.86 | 14.17 | 15.28 | 18.69 | 26.91 | 33.41 | 31.78 |
| Diluted Shares Outstanding (Nos.) | 9 | 9 | 10 | 10 | 10 | 10 | 10 | 10 |
| +Additional Disclosures | 739 | 802 | 893 | 1,119 | 1,324 | 1,577 | 1,870 | 2,214 |
| Sales Growth % | — | 12.51 | 14.44 | 17.37 | 20.82 | 23.36 | 21.37 | 12.30 |
| YoY Sales Growth % | — | 12.51 | 14.44 | 17.37 | 20.82 | 23.36 | 21.37 | 12.30 |
| Material Cost % | 32 | 33 | 34 | 38 | 38 | 34 | 34 | 32 |
| Employee Cost % | 19 | 20 | 18 | 18 | 18 | 18 | 18 | 21 |
| Other Cost % | 26 | 24 | 21 | 21 | 22 | 21 | 22 | 23 |
| OPM % | 21 | 24 | 27 | 23 | 24 | 26 | 27 | 24 |
| Tax % | 35 | 24 | 25 | 25 | 25 | 25 | 25 | 25 |
| Profit Growth % | — | 46.60 | 41.72 | 7.82 | 22.37 | 44.05 | 31.09 | -4.85 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| +Additional Fields | 92 | 123 | 167 | 159 | 208 | 294 | 370 | 327 |
Poly Medicure segment analysis: revenue and profit mix.
Disclosed business segments at Poly Medicure with their share of revenue and profit, switchable between consolidated and standalone reporting.
Poly Medicure discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Poly Medicure Limited.
Our AI distills the core fundamental drivers supporting Poly Medicure Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
Poly Medicure Limited's investment case rests on 10 positive markers and 9 flagged concerns drawn from the latest reported filings.
What you're getting.
Robust Profitability. ROE 15.80% and ROCE 20.10% indicate efficient capital utilization.
Strong Operational Efficiency. Operating Profit Margin of 27.00% highlights healthy core business performance.
Excellent Financial Health. Exceptionally low debt-to-equity ratio of 0.07 signifies minimal financial risk.
High Promoter Confidence. Significant promoter holding of 62.4% reflects strong belief in future.
Consistent Growth Metrics. 5-year EPS CAGR 25.70% and Revenue CAGR 19.43% demonstrate sustained expansion.
What can break it.
High Valuation Multiples. Elevated P/E ratio of 55.04 suggests potential overvaluation relative to earnings.
Recent Stock Volatility. Down 6.44% in 5 days, indicating short-term negative momentum.
Subdued Dividend Growth. 5-year dividend growth rate is negative -8.62%, impacting income investors.
Negative Cash Flow per Share. Annual cash flow per share -8.9421, raising liquidity concerns.
High Price-to-Book Ratio. Price-to-Book of 7.12 suggests premium valuation over assets.
What would change my mind.
Trim if P/E re-rates above 67 (~1.5× the sector multiple of 43.3). The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Poly Medicure Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Poly Medicure Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
Poly Medicure Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Poly Medicure Limited — derived from the live tape, not yesterday's close.
Poly Medicure Limited last traded at ₹1,650.2 with an intraday range of ₹1,615.9–₹1,677 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹1650.20| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1801.70 | +151.50 | +9.18% |
| R3 | 1740.60 | +90.40 | +5.48% |
| R2 | 1708.80 | +58.60 | +3.55% |
| R1 | 1679.50 | +29.30 | +1.78% |
| PIVOT | 1647.70 | -2.50 | -0.15% |
| CURRENT | 1650.20 | — | — |
| S1 | 1496.20 | -154.00 | -9.33% |
| S2 | 1557.30 | -92.90 | -5.63% |
| S3 | 1586.60 | -63.60 | -3.85% |
| S4 | 1618.40 | -31.80 | -1.93% |
POLYMED is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: 1632 ~ 1677
Trading Inside opening range
Poly Medicure Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Poly Medicure Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Poly Medicure Limited stood at 52.4% of traded volume, against a 20-day average of 46.7%.
Poly Medicure announcements: results, concalls, ratings, M&A.
Filings Poly Medicure sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Poly Medicure files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 147 documents below.
Disclosure under SEBI Takeover Regulations
Poly Medicure Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
Disclosure under SEBI Takeover Regulations
Poly Medicure Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
General Updates
Poly Medicure Limited has informed the Exchange about Investor/Analyst Meet
General Updates
Poly Medicure Limited has informed the Exchange about Investors/Analysts Meet Schedule
Analysts/Institutional Investor Meet/Con. Call Updates
Poly Medicure Limited has informed the Exchange about Transcript
Investor decks & rating reports.
Poly Medicure dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Poly Medicure has declared, sequenced by announce and record date.
Poly Medicure corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Poly Medicure Limited: business, sector, key facts.
What Poly Medicure Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Poly Medicure Limited operates in the Medical Equipment & Supplies industry under the Healthcare sector, listed as NSE: POLYMED, BSE: 531768.
Poly Medicure Limited is a prominent Indian medical device manufacturer with a global reach. Their core business revolves around the design, production, and distribution of a wide array of medical devices catering to diverse healthcare needs.
A significant portion of their product portfolio focuses on infusion and fluid management devices. This includes a comprehensive range of intravenous (IV) cannulas, catheters (including central venous and arterial), infusion sets, and associated components like stopcocks, connectors, and syringes. They also offer specialized equipment for blood administration and vascular access.
Beyond infusion, Poly Medicure manufactures a substantial selection of devices for various medical specialties. This includes urology products such as catheters and urine collection systems; respiratory care equipment like endotracheal tubes, oxygen delivery systems, and ventilator circuits; and gastroenterology products such as feeding tubes.
Their offerings extend to critical care and surgical applications, encompassing items like wound drainage systems, suction units, and thoracic drainage catheters. Furthermore, they provide a range of products for blood collection and handling, encompassing needles, tubes, and blood bag systems.
Poly Medicure also caters to the needs of oncology and dialysis patients, manufacturing products such as oncology-related devices, dialyzers, blood lines, and related equipment. Their product line is rounded out by a variety of general medical supplies, including protective equipment, insulin syringes, and various other disposables.
Established in 1995 and headquartered in New Delhi, India, Poly Medicure has cultivated a substantial presence in the medical device market, supplying hospitals and healthcare facilities both domestically and internationally with a diverse range of essential medical supplies.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Laxmi Dental (LAXMIDENTL) Share PricePeer
- Nureca (NURECA) Share PricePeer
- Tarsons Products (TARSONS) Share PricePeer
- Other overvalued NSE stocksScreener
- Top quality scorecard stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Poly Medicure Limited (POLYMED).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Poly Medicure Limited (POLYMED)?
The current share price of Poly Medicure Limited (POLYMED) is ₹1,650.2. Today, the stock has declined by ₹0.70 (0.04%), trading in a range of ₹1,615.9 to ₹1,677. The stock opened at ₹1,653.6 with a trading volume of 1,22,348 shares.
02Is Poly Medicure Limited stock a good investment for long-term?
Poly Medicure Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹16,724.32 crores, P/E ratio of 51.92, ROE of 10.85%, and ROCE of 20.10%. The dividend yield stands at 0.21%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Poly Medicure Limited stock?
The 52-week high price of Poly Medicure Limited (POLYMED) is ₹2,316.6, while the 52-week low is ₹1,182. Currently trading at ₹1,650.2, the stock is 41.3% away from its 52-week low and 28.8% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Poly Medicure Limited stock at the current price?
Whether to buy Poly Medicure Limited stock at ₹1,650.2 depends on multiple factors. The stock is currently trading with a P/E ratio of 51.92 and P/B ratio of 5.38. Today's performance shows a loss of 0.04%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Poly Medicure Limited and when is the next dividend?
Poly Medicure Limited offers a dividend yield of 0.21%, which means for every ₹100 invested at the current price of ₹1,650.2, you can expect to receive approximately ₹0.21 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Poly Medicure Limited?
Poly Medicure Limited's key financial metrics include: P/E Ratio: 51.92, P/B Ratio: 5.38, ROE: 10.85%, ROCE: 20.10%, Dividend Yield: 0.21%, EPS: ₹31.68, Book Value: ₹306.44, and Debt-to-Equity: 0.11. The company's market cap stands at ₹16,724.32 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Poly Medicure Limited stock performing today in the market?
Poly Medicure Limited stock opened at ₹1,653.6 and is currently trading at ₹1,650.2, showing a decline of ₹0.70 (0.04%). The intraday high is ₹1,677 and low is ₹1,615.9. The trading volume stands at 1,22,348 shares, indicating moderate market participation today.
08What is the P/E ratio of Poly Medicure Limited and what does it indicate?
Poly Medicure Limited has a Price-to-Earnings (P/E) ratio of 51.92, which means investors are willing to pay ₹51.92 for every ₹1 of earnings. With an EPS of ₹31.68, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Poly Medicure Limited (POLYMED) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.